Psoriasis and diabetes: A population-based cross-sectional study

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 5, 2008, Pages 585-589

  Cohen, A D ^a,b,g   Dreiher, J ^a   Shapiro, Y ^c   Vidavsky, L ^a   Vardy, D A ^a,b   Davidovici, B ^d   Meyerovitch, J ^a,e,f  

^a CLALIT HEALTH SERVICES   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^c RABIN MEDICAL CENTER   (Israel)

^d KAPLAN MEDICAL CENTER   (Israel)

^e SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^f TEL AVIV UNIVERSITY   (Israel)

^g POB 4317 ^*  (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHI SQUARE TEST; CHILD; CIGARETTE SMOKING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DATA BASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; INFANT; ISRAEL; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PATIENT IDENTIFICATION; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REGISTER; RISK REDUCTION; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INFANT; INFANT, NEWBORN; ISRAEL; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PREVALENCE; PSORIASIS; RETROSPECTIVE STUDIES; RISK FACTORS; SOFTWARE;

EID: 42149124866     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02636.x     Document Type: Article

References (34)

1. Langley RG, Krueger GG, Griffiths CE. Psoriasis. epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005; 64 (Suppl. 2): ii18-ii23.
2. Christophers E. Comorbidities in psoriasis. J Eur Acad Dermatol Venereol 2006; 20: 52-55.
3. Gelfand JM, Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB. Risk of myocardial infarction in patients with psoriasis. JAMA 2006; 296: 1735-1741.
4. Henseler T, Christophers E. Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
5. Lindegard B. Diseases associated with psoriasis in a general population of 159.200 middle-aged, urban, native Swedes. Dermatologica 1986; 172: 298-304.
6. Lindegard B. Mortality and causes of death among psoriatics. Dermatologica 1989; 179: 91-92.
7. Mallbris L, Akre O, Granath F et al. Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients. Eur J Epidemiol 2004; 19: 225-230.
8. Mallbris L, Ritchlin CT, Stahle M. Metabolic disorders in patients with psoriasis and psoriatic arthritis. Curr Rheumatol Rep 2006; 8: 355-363.
9. Mallbris L, Granath F, Hamsten A, Stahle M. Psoriasis is associated with lipid abnormalities at the onset of skin disease. J Am Acad Dermatol 2006; 54: 614-621.
10. McDonald CJ, Calabresi P. Thromboembolic disorders associated with psoriasis. Arch Dermatol 1973; 107: 918.
11. McDonald CJ, Calabresi P. Complication of psoriasis. JAMA 1973; 224: 629.
12. McDonald CJ, Calabresi P. Occlusive vascular disease in psoriatic patients. N Engl J Med 1973; 288: 912.
13. McDonald CJ, Calabresi P. Psoriasis and occlusive vascular disease. Br J Dermatol 1978; 99: 469-475.
14. Naldi L, Chatenoud L, Linder D et al. Cigarette smoking, body mass index, and stressful life events as risk factors for psoriasis: Results from an Italian case-control study. J Invest Dermatol 2005; 125: 61-67.
15. Neimann AL, Shin DB, Wang X, Margolis DJ, Troxel AB, Gelfand JM. Prevalence of cardiovascular risk factors in patients with psoriasis. J Am Acad Dermatol 2006; 55: 829-835.
16. Pearce DJ, Morrison AE, Higgins KB et al. The comorbid state of psoriasis patients in a University dermatology practice. J Dermatolog Treat 2005; 16: 319-323.
17. Shapiro J, Cohen AD, David M et al. The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: A case-control study. J Am Acad Dermatol 2007; 56: 629-634.
18. Sommer DM, Jenisch S, Suchan M, Christophers E, Weichenthal M. Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis. Arch Dermatol Res 2006; 298: 321-328.
19. Stern RS, Lange R. Cardiovascular disease, cancer, and cause of death in patients with psoriasis: 10 years prospective experience in a cohort of 1380 patients. J Invest Dermatol 1988; 91: 197-201.
20. Wakkee M, Thio HB, Prens EP, Sijbrands EJ, Neumann HA. Unfavorable cardiovascular risk profiles in untreated and treated psoriasis patients. Atherosclerosis 2007; 190: 1-9.
21. Rennert G, Peterburg Y. Prevalence of selected chronic diseases in Israel. Isr Med Assoc J 2001; 3: 404-408.
22. Vinker S, Fogelman Y, Elhayany A, Nakar S, Hahan E. Usefulness of electronic databases for the detection of unrecognized diabetes patients. Cardiobasc Diabetol 2003; 2: 13.
23. Bowcock AM. Understanding the pathogenesis of psoriasis, psoriatic arthritis, and autoimmunity via a fusion of molecular genetics and immunology. Immunol Res 2005; 32: 45-56.
24. Mehlis SL, Gordon KB. The immunology of psoriasis and biologic immunotherapy. J Am Acad Dermatol 2003; 49: S44-S50.
25. Devaraj S, Rosenson RS, Jialal I. Metabolic syndrome: An appraisal of the pro-inflammatory and procoagulant status. Endocrinol Metab Clin North Am 2004; 33: 431-453.
26. Yudkin JS. Insulin resistance and the metabolic syndrome - or the pitfalls of epidemiology. Diabetoligia 2007; 50: 1576-1586.
27. Sonnenberg GE, Krakower GR, Kissebah AH. A novel pathway to the manifestations of metabolic syndrome. Obes Res 2004; 12: 180-186.
28. You T, Yang R, Lyles MF, Gong D, Nicklas BJ. Abdominal adipose tissue cytokine gene expression: Relationship to obesity and metabolic risk factors. Am J Physiol Endocrinol Metab 2005; 288: E741-E747.
29. Choi J, Koo JY. Quality of life issues in psoriasis. J Am Acad Dermatol 2003; 49: S57-S61.
30. Mukhtar R, Choi J, Koo JY. Quality-of-life issues in psoriasis. Dermatol Clin 2004; 22: 389-395. viii.
31. Esposito M, Saraceno R, Giunta A, Maccarone M, Chimenti S. An Italian study on psoriasis and depression. Dermatology 2006; 212: 123-127.
32. Patja K, Jousilahti P, Hu G, Valle T, Qiao Q, Tuomilehto J. Effects of smoking, obesity and physical activity on the risk of type 2 diabetes in middle-aged Finnish men and women. J Intern Med 2005; 258: 356-362.
33. Chung CP, Avalos I, Oeser A et al. High prevalence of the metabolic syndrome in patients with systemic lupus erythematosus: Association with disease characteristics and cardiovascular risk factors. Ann Rheum Dis 2007; 66: 208-214.
34. Chung CP, Oeser A, Solus JF et al. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis 2008; 196: 756-763.